File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3201/eid2605.190993
- Scopus: eid_2-s2.0-85083620667
- PMID: 32027587
- WOS: WOS:000529306800016
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings—international travel-related measures
Title | Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings—international travel-related measures |
---|---|
Authors | |
Keywords | disease surveillance human infection control influenza A (H1N1) nonhuman |
Issue Date | 2020 |
Publisher | US Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm |
Citation | Emerging Infectious Diseases, 2020, v. 26 n. 5, p. 961-966 How to Cite? |
Abstract | International travel–related nonpharmaceutical interventions (NPIs), which can include traveler screening, travel restrictions, and border closures, often are included in national influenza pandemic preparedness plans. We performed systematic reviews to identify evidence for their effectiveness. We found 15 studies in total. Some studies reported that NPIs could delay the introduction of influenza virus. However, no available evidence indicated that screening of inbound travelers would have a substantial effect on preventing spread of pandemic influenza, and no studies examining exit screening were found. Some studies reported that travel restrictions could delay the start of local transmission and slow international spread, and 1 study indicated that small Pacific islands were able to prevent importation of pandemic influenza during 1918–19 through complete border closure. This limited evidence base indicates that international travel-related NPIs would have limited effectiveness in controlling pandemic influenza and that these measures require considerable resources to implement. |
Persistent Identifier | http://hdl.handle.net/10722/283684 |
ISSN | 2023 Impact Factor: 7.2 2023 SCImago Journal Rankings: 2.117 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ryu, S | - |
dc.contributor.author | Gao, H | - |
dc.contributor.author | Wong, JY | - |
dc.contributor.author | Shiu, EYC | - |
dc.contributor.author | Xiao, J | - |
dc.contributor.author | Fong, MW | - |
dc.contributor.author | Cowling, BJ | - |
dc.date.accessioned | 2020-07-03T08:22:40Z | - |
dc.date.available | 2020-07-03T08:22:40Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Emerging Infectious Diseases, 2020, v. 26 n. 5, p. 961-966 | - |
dc.identifier.issn | 1080-6040 | - |
dc.identifier.uri | http://hdl.handle.net/10722/283684 | - |
dc.description.abstract | International travel–related nonpharmaceutical interventions (NPIs), which can include traveler screening, travel restrictions, and border closures, often are included in national influenza pandemic preparedness plans. We performed systematic reviews to identify evidence for their effectiveness. We found 15 studies in total. Some studies reported that NPIs could delay the introduction of influenza virus. However, no available evidence indicated that screening of inbound travelers would have a substantial effect on preventing spread of pandemic influenza, and no studies examining exit screening were found. Some studies reported that travel restrictions could delay the start of local transmission and slow international spread, and 1 study indicated that small Pacific islands were able to prevent importation of pandemic influenza during 1918–19 through complete border closure. This limited evidence base indicates that international travel-related NPIs would have limited effectiveness in controlling pandemic influenza and that these measures require considerable resources to implement. | - |
dc.language | eng | - |
dc.publisher | US Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm | - |
dc.relation.ispartof | Emerging Infectious Diseases | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | disease surveillance | - |
dc.subject | human | - |
dc.subject | infection control | - |
dc.subject | influenza A (H1N1) | - |
dc.subject | nonhuman | - |
dc.title | Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings—international travel-related measures | - |
dc.type | Article | - |
dc.identifier.email | Wong, JY: wongytj@hku.hk | - |
dc.identifier.email | Shiu, EYC: eunshiu@connect.hku.hk | - |
dc.identifier.email | Cowling, BJ: bcowling@hku.hk | - |
dc.identifier.authority | Cowling, BJ=rp01326 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3201/eid2605.190993 | - |
dc.identifier.pmid | 32027587 | - |
dc.identifier.pmcid | PMC7181936 | - |
dc.identifier.scopus | eid_2-s2.0-85083620667 | - |
dc.identifier.hkuros | 310744 | - |
dc.identifier.volume | 26 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 961 | - |
dc.identifier.epage | 966 | - |
dc.identifier.isi | WOS:000529306800016 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 1080-6040 | - |